A Risk Model of Eight Immune-Related Genes Predicting Prognostic Response to Immune Therapies for Gastric Cancer

Immune checkpoint inhibitor (ICI) treatment is considered as an innovative approach for cancers. Since not every patient responded well to ICI therapy, it is imperative to screen out novel signatures to predict prognosis. Based on 407 gastric cancer (GC) samples retrieved from The Cancer Genome Atla...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Miao, Zhang, Yi, Mao, Rongchen, Zhu, Chao, Zhao, Ruixue, Jin, Lai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141964/
https://www.ncbi.nlm.nih.gov/pubmed/35627105
http://dx.doi.org/10.3390/genes13050720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9141964/
https://www.ncbi.nlm.nih.gov/pubmed/35627105
http://dx.doi.org/10.3390/genes13050720

Ejemplares similares